ALT R&D Expenses
Altimmune Inc · R&D Expenses
ALT R&D Expenses
Latest reported$68.19Mperiod ending
ALT TTM R&D Expenses ($0.00 → $68.19M)
TTM R&D Expenses
High-resolution chart · PNG
ALT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 68,193,000 | |
| 66,774,000 | |
| 66,432,000 | |
| 67,804,000 | |
| 72,647,000 | |
| 76,566,000 | |
| 82,226,000 | |
| 79,354,000 | |
| 77,939,000 | |
| 70,037,000 | |
| 65,799,000 | |
| 68,069,000 | |
| 69,943,000 | |
| 72,683,000 | |
| 70,538,000 | |
| 71,544,000 | |
| 80,488,000 | |
| 77,767,000 | |
| 74,541,000 | |
| 63,306,572 | |
| 51,142,547 | |
| 54,464,797 | |
| 49,774,328 | |
| 44,696,845 | |
| 36,384,567 | |
| 22,735,413 | |
| 18,765,553 | |
| 17,957,158 | |
| 13,956,187 | |
| 15,930,052 | |
| 18,459,352 | |
| 19,854,584 | |
| 21,031,410 | |
| 21,367,178 | |
| 16,346,004 | |
| 13,313,108 | |
| 8,644,248 | |
| 4,532,701 | |
| 4,836,035 | |
| 4,580,498 | |
| 4,469,671 | |
| 4,549,016 | |
| 5,133,512 | |
| 5,753,231 | |
| 6,356,295 | |
| 7,506,455 | |
| 9,319,828 | |
| 11,626,355 | |
| 12,453,809 | |
| 13,483,667 | |
| 15,290,142 | |
| 15,939,398 | |
| 18,521,637 | |
| 20,037,747 | |
| 19,509,629 | |
| 19,293,784 | |
| 19,039,393 | |
| 20,104,836 | |
| 21,219,853 | |
| 20,499,339 | |
| 21,787,255 | |
| 21,743,517 | |
| 20,875,536 | |
| 24,514,909 | |
| 25,952,556 | |
| 29,476,825 | |
| 30,219,758 | |
| 28,106,744 | |
| 29,911,043 | |
| 31,630,702 | |
| 31,812,431 | |
| 32,300,814 | |
| 26,534,050 | |
| 15,349,762 | |
| 9,472,707 | |
| 3,647,329 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |